Laura Treye Weissman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospital Departments | 1 | 2018 | 134 | 0.590 |
Why?
|
| Personnel, Hospital | 1 | 2018 | 285 | 0.520 |
Why?
|
| Autistic Disorder | 3 | 2023 | 1238 | 0.350 |
Why?
|
| Language Development Disorders | 2 | 2014 | 194 | 0.340 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3927 | 0.230 |
Why?
|
| Social Behavior | 1 | 2010 | 1147 | 0.220 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 4056 | 0.210 |
Why?
|
| Curriculum | 2 | 2021 | 3783 | 0.130 |
Why?
|
| Mass Screening | 1 | 2010 | 5454 | 0.120 |
Why?
|
| SOXC Transcription Factors | 1 | 2013 | 41 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2013 | 127 | 0.110 |
Why?
|
| Program Development | 1 | 2018 | 1297 | 0.100 |
Why?
|
| Cerebral Hemorrhage | 1 | 2003 | 2654 | 0.090 |
Why?
|
| Chromosome Disorders | 1 | 2014 | 498 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2018 | 2504 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 1384 | 0.080 |
Why?
|
| Caregivers | 1 | 2021 | 2303 | 0.080 |
Why?
|
| Hospitals | 1 | 2021 | 3888 | 0.070 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2014 | 1988 | 0.070 |
Why?
|
| Pleural Neoplasms | 1 | 1991 | 584 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2010 | 1186 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 2045 | 0.060 |
Why?
|
| Child | 5 | 2023 | 80668 | 0.060 |
Why?
|
| Mesothelioma | 1 | 1991 | 774 | 0.060 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2010 | 597 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 1519 | 0.060 |
Why?
|
| Pneumonectomy | 1 | 1991 | 1147 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2746 | 0.060 |
Why?
|
| Dilatation, Pathologic | 1 | 2003 | 527 | 0.050 |
Why?
|
| Cerebral Ventricles | 1 | 2003 | 550 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 642 | 0.040 |
Why?
|
| Epilepsy | 1 | 2014 | 3317 | 0.040 |
Why?
|
| Streptococcus agalactiae | 1 | 1999 | 337 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2010 | 3591 | 0.030 |
Why?
|
| Parents | 1 | 2010 | 3593 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7868 | 0.030 |
Why?
|
| Humans | 15 | 2023 | 766766 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14652 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 12985 | 0.030 |
Why?
|
| Infant | 3 | 2014 | 36461 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 1999 | 618 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 3 | 1991 | 2730 | 0.030 |
Why?
|
| Communication | 2 | 2021 | 3905 | 0.030 |
Why?
|
| Male | 8 | 2018 | 364142 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 474 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1999 | 1354 | 0.020 |
Why?
|
| Inpatients | 1 | 2023 | 2565 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 18075 | 0.020 |
Why?
|
| Thiotepa | 1 | 1990 | 66 | 0.020 |
Why?
|
| Pleura | 1 | 1991 | 245 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 1991 | 11872 | 0.020 |
Why?
|
| Diaphragm | 1 | 1991 | 357 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 935 | 0.020 |
Why?
|
| Karyotyping | 1 | 2010 | 1176 | 0.020 |
Why?
|
| Female | 8 | 2018 | 396520 | 0.020 |
Why?
|
| Health Personnel | 1 | 2021 | 3384 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 751 | 0.020 |
Why?
|
| Pericardium | 1 | 1991 | 681 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3796 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5368 | 0.020 |
Why?
|
| Adult | 4 | 2018 | 223307 | 0.020 |
Why?
|
| Drug Evaluation | 3 | 1991 | 642 | 0.020 |
Why?
|
| Combined Modality Therapy | 3 | 1991 | 8540 | 0.010 |
Why?
|
| Carboplatin | 3 | 1991 | 789 | 0.010 |
Why?
|
| Ifosfamide | 2 | 1991 | 233 | 0.010 |
Why?
|
| Genome, Human | 1 | 2013 | 4443 | 0.010 |
Why?
|
| Survival Rate | 2 | 1991 | 12825 | 0.010 |
Why?
|
| Hospitalization | 1 | 1999 | 10823 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2013 | 42577 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2014 | 6282 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 9525 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 88904 | 0.010 |
Why?
|
| Hospital Costs | 1 | 1999 | 955 | 0.010 |
Why?
|
| Health Resources | 1 | 1999 | 951 | 0.010 |
Why?
|
| Drug Administration Schedule | 2 | 1991 | 4853 | 0.010 |
Why?
|
| Neoplasms | 2 | 1991 | 22350 | 0.010 |
Why?
|
| Mesna | 1 | 1991 | 62 | 0.010 |
Why?
|
| Carmustine | 1 | 1990 | 137 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2014 | 81635 | 0.010 |
Why?
|
| Cost of Illness | 1 | 1999 | 1949 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1991 | 15831 | 0.000 |
Why?
|
| Organoplatinum Compounds | 1 | 1990 | 406 | 0.000 |
Why?
|
| Melphalan | 1 | 1990 | 425 | 0.000 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1999 | 2184 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2010 | 41710 | 0.000 |
Why?
|
| Hematologic Diseases | 1 | 1991 | 502 | 0.000 |
Why?
|
| Massachusetts | 1 | 1999 | 8891 | 0.000 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1991 | 497 | 0.000 |
Why?
|
| Transplantation, Autologous | 1 | 1991 | 2127 | 0.000 |
Why?
|
| Length of Stay | 1 | 1999 | 6490 | 0.000 |
Why?
|
| Creatinine | 1 | 1991 | 1917 | 0.000 |
Why?
|
| Remission Induction | 1 | 1991 | 2413 | 0.000 |
Why?
|
| Cyclophosphamide | 1 | 1990 | 2234 | 0.000 |
Why?
|
| Cisplatin | 1 | 1990 | 1655 | 0.000 |
Why?
|
| Young Adult | 1 | 2010 | 59939 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1990 | 21162 | 0.000 |
Why?
|
| Middle Aged | 3 | 1991 | 223257 | 0.000 |
Why?
|
| Nervous System Diseases | 1 | 1991 | 1659 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1991 | 2101 | 0.000 |
Why?
|
| Sarcoma | 1 | 1991 | 1802 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1999 | 26389 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1991 | 10745 | 0.000 |
Why?
|
| Pregnancy | 1 | 1999 | 30237 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1990 | 11218 | 0.000 |
Why?
|